Anatomical Therapeutic Chemical • L02BA05 • camizestrant

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L02 Endocrine therapy

L02A Hormones and related agents

L02B Hormone antagonists and related agents

L02BA Anti-estrogens

L02BA01 tamoxifen Indicated for: breast cancer

L02BA02 toremifene Indicated for: breast cancer

L02BA03 fulvestrant Indicated for: breast cancer

L02BA04 elacestrant Indicated for: breast cancer

L02BA05 camizestrant Indicated for: ER-positive, HER2-negative locally advanced or metastatic breast cancer with an ESR1 mutation detected without progressi

L02BB Anti-androgens

L02BG Aromatase inhibitors

L02BX Other hormone antagonists and related agents

L03 Immunostimulants

L04 Immunosuppressants

M Musculo-skeletal system

N Nervous system

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various